Orotech SA
1.6 FTEThe score of Orotech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +45 % Total assets +67 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Orotech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Orotech's financial analysis
- Solvency74.8%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Orotech
Orotech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.916.118
- VAT number
- BE0877916118
- Peppol
- Registered · 0208:0877916118 · as of 09 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Nov 2005
- Registered office
- 9140 Temse
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Orotech (SA) has been based in Temse since 2005, active in: manufacture of medicaments. For 2025, it reports a net profit of 30,757 € and equity of 909,065 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 74.8%, above the median of its sector (47.2%).
Companies similar to Orotech
Companies in the same business, of comparable size and area, outside its group.
- Shant Laboratories Belgium Manufacture of basic pharmaceutical products Tubize · balance sheet €1.06m
- Obulytix Manufacture of pharmaceutical preparations Ghent · balance sheet €5.29m
- AnimAb Manufacture of pharmaceutical preparations Ghent · balance sheet €3.47m
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- ExoXpert Manufacture of pharmaceutical preparations Liège · balance sheet €2.05m
- Xedev Other information service activities Zele · balance sheet €2.72m
- Plant Bio Technologies Manufacture of basic pharmaceutical products Ghent · balance sheet €1.04m
- OLYS Pharma Manufacture of pharmaceutical preparations La Hulpe · balance sheet €1.03m
Frequently asked questions about Orotech
What is the revenue of Orotech?
Orotech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Orotech?
In Belgium, the VAT number is the company number prefixed with BE: BE0877916118 for Orotech, if the company is VAT-registered. Its company number (CBE) is 0877.916.118.
Where is the registered office of Orotech?
According to the CBE register, the registered office of Orotech is in 9140 Temse.
What is the equity of Orotech?
At the close of the 2025 financial year, the equity of Orotech amounts to 909,065 €, a solvency of 74.8% of total assets.
How many people work at Orotech?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Orotech?
The register lists 5 active mandates at Orotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Orotech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →